Basking Ridge, NJ March 23, 2016 — Valiance Partners, developer of the TRUmigrate and TRUcompare data migration applications and the Migration Insight migration methodology, announces a newly formed partnership with Bioclinica, a leading supplier of EDC, Data Management, and CTMS applications.
Valiance solves a key challenge in the highly regulated life sciences industry, where companies often struggle with complex migrations from many different applications and platforms, each with their own set of processes and databases. Through this partnership, Bioclinica may utilize Valiance Partners’ data and content migration services to augment its own substantial capabilities on specific engagements where warranted.
Typical data migrations require complex custom coding, ETL, application loaders and use some form of sample-based testing. According to Valiance President Rick Higger, whose team has led global life sciences migrations for most of the largest life science companies in the industry, “The risks associated with common, customized migration tools and testing techniques in life sciences are significant. We offer purpose-built, configurable migration software solutions and automated testing services that Bioclinica may tap, should the need arise to augment its own substantial data migration capabilities. Valiance Partners’ data migration services are predictable, efficient, and 100 percent verified.”
Valiance Partners is the leading vendor for high-risk data and content migrations where compliance and business risk demand “getting it right.” For more than eight years, Valiance has managed hundreds of successful migrations for the world’s leading pharmaceutical, medical device and biotechnology brands. They bring an unparalleled knowledge of regulations, business processes and precision results to every client engagement.
Valiance’s software products, TRUmigrate and TRUcompare, provide end-to-end data and content migration software solutions for IT, quality, validation and test management. In addition, our professional services help clients embark on migrations with the technology, business and compliance knowledge needed to succeed in regulated industries.
Bioclinica is a specialty services provider that utilizes expertise and technology to create clarity in the clinical trial process. Bioclinica is organized by three business segments to deliver focused service supporting multifaceted technologies. The Medical Imaging and Biomarkers segment provides medical imaging and cardiac safety services and includes a molecular marker laboratory. The eHealth Solutions segment comprises an eClinical technology platform and professional services along with safety and regulatory solutions. Under the Global Clinical Research segment, Bioclinica offers a network of research sites, patient recruitment-retention services, and a post-approval research division. The Company serves more than 400 pharmaceutical, biotechnology and device organizations – including all of the top 20 – through a network of offices in the U.S., Europe and Asia. Learn more at www.bioclinica.com.
Migrations are a complex undertaking and traditional testing approaches often fall short of today’s business and compliance requirements. The ensuing risk can easily result in costly errors. The question is: How sound are your current testing and sampling approaches?